SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Olympus Corporation (OCPNY) trades at a trailing P/E of 0.2. Trailing earnings yield is 500.00%.
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.2); earnings yield beats bond yields (500.00%).
- Trailing Earnings Yield 500.00% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 77/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OCPNY
Valuation Multiples
P/E (TTM)0.2
Forward P/EN/A
PEG Ratio0.00
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.03
EV/EBITDA0.0
Per Share Data
EPS (TTM)$90.35
Book Value / Share$0.00
Revenue / Share$676.90
FCF / Share$0.00
Yields & Fair Value
Earnings Yield500.00%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$7.24 |
$743.85B |
$8.02B |
1.1% |
| 2014 |
$10.26 |
$713.29B |
$13.63B |
1.9% |
| 2015 |
$-6.38 |
$764.67B |
$-8.74B |
-1.1% |
| 2016 |
$45.71 |
$804.58B |
$62.59B |
7.8% |
| 2017 |
$57.10 |
$748.05B |
$78.19B |
10.5% |
| 2018 |
$41.69 |
$786.5B |
$57.06B |
7.3% |
| 2019 |
$5.96 |
$793.86B |
$8.15B |
1% |
| 2020 |
$39.36 |
$797.41B |
$51.67B |
6.5% |
| 2021 |
$10.04 |
$730.54B |
$12.92B |
1.8% |
| 2022 |
$90.35 |
$868.87B |
$115.97B |
13.3% |
